Alan and Helene Goldberg grant
07.01.2020
We are very happy to announce that our project “Analysis of Parkinson’s disease associated alpha-Synuclein aggregate toxicity in patient specific brain organoids” has been selected for funding via the Alan and Helene Goldberg grant (CAAT grant).
This is a great achievement for OrganoTherapeutics and we are looking forward to start working on this project in March 2020.